Rentschler Biopharma logo from PR.jpg
Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational
July 11, 2024 08:00 ET | Rentschler Biopharma SE
Largest expansion in company’s 150+-year history opensMajor client project already underway; new clients actively being onboarded LAUPHEIM, Germany and MILFORD, Mass., July 11, 2024 (GLOBE...
Cellectis Logo.png
Monthly information on share capital and company voting rights
July 05, 2024 16:30 ET | Cellectis Inc.
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, July 05, 2024 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 DateTotal number...
blue-mountain-logo-blue 1 1.png
Blue Mountain and Zifo, Global Leaders in Life Sciences Pharmaceutical Manufacturing, Announce Strategic Partnership to Revolutionize Enterprise Asset Management
June 27, 2024 09:00 ET | Blue Mountain
Blue Mountain and Zifo announce a partnership to enhance efficiency and innovation in the life sciences sector, offering advanced solutions for GMP.
Cellectis Logo.png
Cellectis Publishes a Scientific Article Unveiling Three Key Factors for Efficient TALE Base Editing
June 20, 2024 16:30 ET | Cellectis Inc.
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ:  CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to...
NodThera_logo.jpg
NodThera’s NLRP3 Inhibitor NT-0796 Meets Primary Endpoint of Inflammation Reversal in Phase Ib/IIa Trial in Obese Subjects with Cardiovascular Risk
June 12, 2024 07:00 ET | NodThera
NodThera Ltd (“NodThera” or the “Company”) NodThera’s NLRP3 Inhibitor NT-0796 Meets Primary Endpoint of Inflammation Reversal in Phase Ib/IIa Trial in Obese Subjects with Cardiovascular Risk ...
DMR Logo.png
Cell Therapy Market Is Expected To Reach a Revenue Of USD 32.5 Bn By 2033, At 18.6% CAGR | Dimension Market Research
June 10, 2024 12:01 ET | Dimension Market Research
New York, June 10, 2024 (GLOBE NEWSWIRE) -- Market Overview The Global Cell Therapy Market size is expected to reach USD 7.0 billion by 2024 and is further anticipated to reach USD 32.5 billion by...
DMR Logo.png
CDMO Market Forecast USD 530.3 Billion by 2033 at 7.7% CAGR Growth Rate | Dimension Market Research
June 10, 2024 10:57 ET | Dimension Market Research
New York, June 10, 2024 (GLOBE NEWSWIRE) -- Overview The Global CDMO Market size is expected to reach USD 272.4 billion by 2024 and is further anticipated to reach USD 530.3 billion by 2033 at a...
DMR Logo.png
Biopharmaceutical Market to Reach USD 1,829.2 Billion by 2033, Growing at 15.4% CAGR | Dimension Market Research
June 10, 2024 10:12 ET | Dimension Market Research
New York, June 10, 2024 (GLOBE NEWSWIRE) -- Overview: The Global Biopharmaceutical Market size reached USD 436.7 billion in 2023 and is further anticipated to reach USD 1,829.2 billion by 2033...
Rhino Health to Deliver Enterprise Federated Computing Solutions in Collaboration With NVIDIA
June 10, 2024 05:00 ET | Rhino Health
BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Rhino Health, the global leader in federated computing, today announced a collaboration with NVIDIA to provide an enterprise-hardened federated computing...
Rhino Health to Deliver Federated Computing Platform to Regulated Industries with Google Cloud
June 03, 2024 05:00 ET | Rhino Health
Rhino Health and Google Cloud announce partnership for Federated Learning to connect data silos in life sciences, healthcare, financial services, and more